Valuation: Novartis AG

Market Cap 266B 237B 221B 201B 380B 25,653B 382B 2,672B 1,039B 13,082B 1,000B 978B 42,053B P/E 2026 *
19.7x
P/E 2027 * 16.6x
Enterprise Value 298B 265B 247B 225B 424B 28,677B 427B 2,987B 1,161B 14,624B 1,118B 1,094B 47,010B EV / Sales 2026 *
5.16x
EV / Sales 2027 * 4.8x
Free-Float
91.66%
Yield 2026 *
3.1%
Yield 2027 * 3.23%
Manager TitleAgeSince
Chief Executive Officer 50 31/01/2018
Director of Finance/CFO - 15/03/2026
Compliance Officer 58 13/04/2025
Director TitleAgeSince
Director/Board Member 67 31/12/2014
Director/Board Member 69 31/12/2015
Director/Board Member 61 31/12/2015
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 267B
+0.02%-3.41%+36.11%+115.09% 1,019B
-1.21%-6.74%+34.08%+62.64% 617B
+1.12%+0.54%+13.62%+79.94% 464B
-3.30%-6.21%+56.45%+36.58% 356B
+0.93%-3.16%+21.65%+43.02% 333B
+0.12%-2.77%+10.70%+32.97% 267B
-0.89%-6.28%-7.00%+8.01% 244B
-0.01%-2.81%+35.28%+51.82% 218B
-0.08%-4.17%+28.34%+93.51% 179B
Average -0.30%-3.54%+25.47%+58.17% 410.8B
Weighted average by Cap. -0.14%-3.54%+28.50%+70.11%

Financials

2026 *2027 *
Net sales 57.7B 51.42B 47.93B 43.63B 82.21B 5,556B 82.76B 579B 225B 2,834B 217B 212B 9,108B 61.42B 54.73B 51.02B 46.45B 87.52B 5,915B 88.1B 616B 240B 3,016B 231B 226B 9,696B
Net income 14.26B 12.7B 11.84B 10.78B 20.31B 1,373B 20.45B 143B 55.6B 700B 53.52B 52.36B 2,251B 15.8B 14.08B 13.12B 11.95B 22.51B 1,521B 22.66B 158B 61.6B 776B 59.3B 58.01B 2,494B
Net Debt 31.4B 27.98B 26.09B 23.75B 44.75B 3,024B 45.04B 315B 122B 1,542B 118B 115B 4,957B 28.22B 25.15B 23.44B 21.34B 40.21B 2,718B 40.48B 283B 110B 1,386B 106B 104B 4,455B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
140.15USD
Average target price
151.69USD
Spread / Average Target
+8.24%

Quarterly revenue - Rate of surprise